title: [Patient with reactivation of hepatitis B after chemotherapy. Role of lamivudine therapy].
authors.forename: Sonia
authors.initials: S
authors.lastname: Maciá Escalante
authors.forename: Alvaro
authors.initials: A
authors.lastname: Rodríguez Lescure
authors.forename: Mariana Fe
authors.initials: MF
authors.lastname: García Sepulcre
authors.forename: Carmen
authors.initials: C
authors.lastname: Guillén Ponce
authors.forename: Alfredo
authors.initials: A
authors.lastname: Carrato Mena
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D005260:Female; D006510:Hepatitis B Antibodies / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D014775:Virus Activation
chemical_list: D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine